DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Net Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹15,201 Cr | ₹11,744 Cr | ₹8,022 Cr | ₹6,431 Cr | ₹5,385 Cr |
What is the latest Net Current Assets ratio of DR REDDYS LABORATORIES ?
Year | Net Current Assets |
---|---|
Mar2024 | ₹15,201 Cr |
Mar2023 | ₹11,744 Cr |
Mar2022 | ₹8,022 Cr |
Mar2021 | ₹6,431 Cr |
Mar2020 | ₹5,385 Cr |
How is Net Current Assets of DR REDDYS LABORATORIES Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹15,201 Cr | 29.43 | |
Mar2023 | ₹11,744 Cr | 46.40 | |
Mar2022 | ₹8,022 Cr | 24.73 | |
Mar2021 | ₹6,431 Cr | 19.43 | |
Mar2020 | ₹5,385 Cr | - |
Compare Net Current Assets of peers of DR REDDYS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DR REDDYS LABORATORIES | ₹100,870.6 Cr | -0.4% | -8.2% | 7.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹422,271.0 Cr | -0.9% | -4.8% | 50.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,183.0 Cr | 3% | 5.9% | 65% | Stock Analytics | |
CIPLA | ₹120,605.0 Cr | 1.5% | 0.1% | 19.9% | Stock Analytics | |
MANKIND PHARMA | ₹103,515.0 Cr | 0.6% | 3.1% | 34.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,808.6 Cr | 0.6% | -5.3% | 51% | Stock Analytics |
DR REDDYS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR REDDYS LABORATORIES | -0.4% |
-8.2% |
7.1% |
SENSEX | 3.5% |
-0.1% |
21.9% |
You may also like the below Video Courses